Press Release: Seraphina : Seraphina Therapeutics Announces C15:0, an Essential Fatty Acid, Reverses Key Components of Cellular Fragility Syndrome in a Second, Independent Model

New study further supports the role of C15:0 in preventing and reversing the alarming rise in liver disease. SAN DIEGO, July 1, 2025 /PRNewswire/ -- A new independent study has revalidated the use of C15:0 to reverse core components of a newly discovered nutritional C15:0 deficiency...